Figure 2.

Geographical distribution of the study participants. In total, 246 members across 46 countries from every continent except Antarctica participated in the COVID-19 discussion. The United Kingdom had the greatest number of study participants at 62 (25.2%), with the United States being second with 54 (22%) participants and India being third with 16 (6.5%) participants.